lithium has been researched along with carbostyril in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (45.45) | 29.6817 |
| 2010's | 6 (54.55) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tomioka, K; Yamada, K; Yamashita, M | 1 |
| Bark, N; Citrome, L; Josiassen, R; Mallikaarjun, S; Salazar, DE | 1 |
| Keck, PE | 1 |
| Kawamoto, Y; Sakai, T; Tomioka, K | 1 |
| Ali, S; Patel, P; Pearlman, RL; Upadhyay, A | 1 |
| McIntyre, RS | 1 |
| Carson, W; Khan, A; Marcus, R; Morris, B; Rollin, L; Sanchez, R; Timko, K | 1 |
| Healy, D; Jureidini, JN; Parry, PI; Rosenlicht, NZ; Spielmans, GI; Tsai, AC | 1 |
| Caron, MG; Jacobsen, JP; Peterson, SM; Snyder, JC; Urs, NM | 1 |
| Baker, RA; Carlson, BX; De Hert, M; Eudicone, JM; Fyans, P; Kemp, DE; Marler, SV; Rahman, Z | 1 |
| Malempati, RN | 1 |
3 review(s) available for lithium and carbostyril
| Article | Year |
|---|---|
The role of second-generation antipsychotic monotherapy in the rapid control of acute bipolar mania.
Topics: Acute Disease; Anticonvulsants; Antipsychotic Agents; Aripiprazole; Basal Ganglia Diseases; Benzodiazepines; Bipolar Disorder; Clozapine; Dibenzothiazepines; Double-Blind Method; Humans; Lithium; Olanzapine; Piperazines; Placebos; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Risperidone; Treatment Outcome | 2005 |
Aripiprazole for the maintenance treatment of bipolar I disorder: A review.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Double-Blind Method; Humans; Lithium; Metabolic Diseases; Obesity; Piperazines; Quinolones; Randomized Controlled Trials as Topic; Secondary Prevention; Treatment Outcome | 2010 |
Aripiprazole in the maintenance treatment of bipolar disorder: a critical review of the evidence and its dissemination into the scientific literature.
Topics: Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Evidence-Based Medicine; Humans; Lithium; Piperazines; Quinolones; Randomized Controlled Trials as Topic; Secondary Prevention; Treatment Outcome | 2011 |
2 trial(s) available for lithium and carbostyril
| Article | Year |
|---|---|
Efficacy of aripiprazole adjunctive to lithium or valproate in the long-term treatment of patients with bipolar I disorder with an inadequate response to lithium or valproate monotherapy: a multicenter, double-blind, randomized study.
Topics: Adult; Antimanic Agents; Aripiprazole; Bipolar Disorder; Confidence Intervals; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Lithium; Longitudinal Studies; Male; Middle Aged; Piperazines; Psychiatric Status Rating Scales; Quinolones; Time Factors; Treatment Outcome; Valproic Acid | 2011 |
Investigation into the long-term metabolic effects of aripiprazole adjunctive to lithium, valproate, or lamotrigine.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Body Weight; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Lamotrigine; Lithium; Male; Metabolic Syndrome; Middle Aged; Obesity; Overweight; Piperazines; Quinolones; Time Factors; Treatment Outcome; Triazines; Valproic Acid | 2013 |
6 other study(ies) available for lithium and carbostyril
| Article | Year |
|---|---|
Construction of arene-fused-piperidine motifs by asymmetric addition of 2-trityloxymethylaryllithiums to nitroalkenes: the asymmetric synthesis of a dopamine D1 full agonist, A-86929.
Topics: Alkenes; Dopamine Agonists; Lithium; Nitro Compounds; Organometallic Compounds; Piperidines; Quinolones; Receptors, Dopamine D1; Stereoisomerism; Thiophenes | 2004 |
Pharmacokinetics of aripiprazole and concomitant lithium and valproate.
Topics: Adult; Aripiprazole; Drug Therapy, Combination; Humans; Lithium; Male; Middle Aged; Piperazines; Psychotic Disorders; Quinolones; Schizophrenia; Valproic Acid | 2005 |
Asymmetric synthesis of intermediates for otamixaban and premafloxacin by the chiral ligand-controlled asymmetric conjugate addition of a lithium amide.
Topics: Amides; Cyclic N-Oxides; Fluoroquinolones; Ligands; Lithium; Pyridines; Pyrroles; Quinolones; Stereoisomerism | 2006 |
Neuroleptic malignant syndrome with aripiprazole and lithium: a case report.
Topics: Administration, Oral; Adult; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Humans; Lithium; Male; Neuroleptic Malignant Syndrome; Piperazines; Quinolones | 2006 |
Deletion of GSK3β in D2R-expressing neurons reveals distinct roles for β-arrestin signaling in antipsychotic and lithium action.
Topics: Animals; Antipsychotic Agents; Aripiprazole; Arrestins; Behavior, Animal; beta Catenin; beta-Arrestins; Dopaminergic Neurons; Gene Knockout Techniques; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Lithium; Mice; Mice, 129 Strain; Mice, Inbred C57BL; Mice, Knockout; Motor Activity; Piperazines; Quinolones; Receptors, Dopamine D2; Signal Transduction | 2012 |
Aripiprazole adjunct treatment in bipolar I or II disorder, depressed state: a 2-year clinical study.
Topics: Adult; Anticonvulsants; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Drug Synergism; Drug Therapy, Combination; Female; Humans; Lithium; Male; Middle Aged; Piperazines; Quinolones; Time Factors; Treatment Outcome; Young Adult | 2015 |